#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ataxia telangiectasia Osteosarcoma Small for dates baby Mitochondrial myopathy Staphylococcal infection Chronic hepatitis B Chondrosarcoma Cardiomyopathy Neuroendocrine carcinoma Philadelphia positive chronic myeloid leukaemia Malignant peritoneal neoplasm Dent's disease Chronic cutaneous lupus erythematosus Acute hepatic failure Mantle cell lymphoma stage III More trials…

    Learn about Rare Diseases

    Alexander disease Congenital nephrogenic diabetes insipidus Hyperoxaluria Cerebral arteriovenous malformation haemorrhagic Haemophilia B without inhibitors – Treatment Hairy cell leukaemia – Treatment Hereditary ataxia Anaplastic thyroid cancer Congenital generalised lipodystrophy – Life with Disease Marfan’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Indometacin Ph. Eur. Metamizole Sodium Monohydrate Ustekinumab SUMATRIPTAN Etidronate Disodium Everolimus Propranolol Hydrochloride Isosorbide Dinitrate Afm24 Simoctocog Alfa Testosterone Undecanoate Birtamimab Hydrocortisone Streptococcus Agalactiae Etrumadenant Lisdexamfetamine Dimesylate Atogepant Lepidoglyphus Destructor Pseudoephedrine Hydrochloride Setmelanotide More therapies…

    Learn about Your Condition

    Exudative retinopathy Pyoderma Head and neck cancer stage III Immune-mediated renal disorder Pancreatitis acute Anal cancer recurrent Immunodeficiency congenital Atopic keratoconjunctivitis Penile squamous cell carcinoma Bile acid synthesis disorder Inflammation Breast neoplasm Coronary artery disease Breast cancer in situ Systemic infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study of BCG Vaccine and Sodium Chloride for Patients with Radiologically Isolated Syndrome (RIS)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Radiologically isolated syndrome
    Investigated Drugs:
    • Live Bcg Bacilli (Bacillus Calmette-Guerin), Brasilian Moreau Substrain
    • Sodium Chloride
    Italy

  • Study on Clemizole Hydrochloride for Children and Adults with Dravet Syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Severe myoclonic epilepsy of infancy
    Investigated Drugs:
    • Clemizole Hydrochloride
    Hungary Poland Spain

  • Study on the Use of Alteplase and Andexanet Alfa for Patients with Acute Ischemic Stroke on Non-Vitamin K Oral Anticoagulants

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Alteplase
    • Andexanet Alfa
    Poland

  • Study on Ethinylestradiol/Levonorgestrel and Vitamin E for Treating Menstrual and Perimenopausal Migraines in Women

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Alpha-Tocopherol
    • Ethinylestradiol
    • Levonorgestrel
    The Netherlands

  • Study on Statins for Frail Older Patients with Recent Ischemic Stroke or TIA: Fluvastatin, Simvastatin, Pravastatin Sodium, Atorvastatin, and Rosuvastatin Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Fluvastatin
    • Simvastatin
    • Atorvastatin
    The Netherlands

  • Study on Efgartigimod for Early Treatment in Patients with Generalized Myasthenia Gravis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Efgartigimod Alfa
    Spain
Previous Page
1 … 26 27 28 29 30 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!